Opinion

Video

Recent Data on Bimekizumab for Hidradenitis Suppurativa

Vivian Shi, MD, FAAD, reviews recent phase 3 data on bimekizumab, a biologic therapy for patients with hidradenitis suppurativa.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
2 experts in this video
2 experts in this video
1 expert in this video
1 expert in this video
2 experts in this video
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo